JPMorgan keeps its EUR 55.20 target for Fresenius stock

Published on 10/27/2026 at 16:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q2 2026 revenue reached EUR 5.864 billion. Fresenius stock costs EUR 46.32 on October 27, 2026, minus 0.30 percent versus Xetra close.

Analyst target and results

JPMorgan kept its EUR 55.20 target for Fresenius on October 26, 2026.
Second-quarter 2026 revenue reached EUR 5.864 billion.
Fresenius stock cost EUR 46.32 at Lang & Schwarz on October 27, 2026, minus 0.30 percent versus the Xetra close.
Fresenius is scheduled to publish third-quarter 2026 results on November 4, 2026.

Fresenius, DE000FRE5EN2, Illustration mit AI erstellt.

Fresenius (ISIN DE000FRE5EN2) is covered by a EUR 55.20 price target from JPMorgan, while the stock traded at EUR 46.32 at Lang & Schwarz on October 27, 2026 at 4:07 p.m. CET, minus 0.30 percent versus the Xetra close of October 26, 2026 at EUR 46.46. According to Deutsche Boerse on October 26, 2026, JPMorgan kept its Overweight rating and EUR 55.20 target. The target stands 19.17 percent above the Lang & Schwarz price.

What does the target imply?

The analyst view arrives before Fresenius reports third-quarter results. JPMorgan expects revenue 1.60 percent above consensus and adjusted operating profit in line with expectations, according to the same October 26, 2026 note from Deutsche Boerse. A second analyst view was more constructive on the target level: Berenberg raised its target from EUR 50.00 to EUR 54.00 and kept a Buy rating, with the underlying note dated October 22, 2026, as reported by MarketScreener.

The stock stays below its high

Fresenius traded 12.54 percent below its 52-week high of EUR 52.96 and 31.93 percent above its 52-week low of EUR 35.11 on October 27, 2026. The company had a market capitalization of EUR 26.1 billion and a price-to-earnings ratio of 16.82 on the same date. Its Xetra share price was below the previous session close by 0.30 percent at the Lang & Schwarz timestamp.

Results date and operating base

Fresenius is scheduled to publish its third-quarter 2026 results on November 4, 2026, according to the company's investor-relations page. The latest reported quarter was the second quarter of 2026, when revenue reached EUR 5.864 billion, up 6.00 percent from EUR 5.571 billion in the second quarter of 2025. Adjusted operating profit reached EUR 719.0 million, up 10.00 percent from EUR 654.0 million. These figures are published by Fresenius.

Trading level after the Xetra close

The current price places Fresenius below both the JPMorgan target and the 52-week high, while the latest quarterly figures show revenue growth of 6.00 percent and adjusted operating profit growth of 10.00 percent. The next scheduled reporting date is November 4, 2026. The further course of trading is shown by the continuously updated real-time quote of Fresenius stock.